GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · BSE Equity Only

BSE Exchange Filings, Explained Simply

AI-powered plain-English analysis of every important BSE announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Today
—
Total
BSE
Exchange
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Strictly sourced from BSE exchange announcements (equity segment only). We show only material, important filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India exchange announcements. More categories will be added over time.
Choksi Laboratories Ltd
Result as attached
RESULTS ● No Immediate Change LOW RISK
📅 Filed on BSE: 25 May 2026, 04:39 PM IST  ·  BSE ID: 33532393-13b8-4b5e-9db6-f988b09fe4d6
View Original BSE Filing (PDF)
💡
In Simple Terms
Choksi Laboratories submitted its audited financial reports for the recent quarter and full financial year, with auditor approval.
🤖 AI Summary
  • Choksi Laboratories Limited submitted Audited Financial Results for Q4 FY26 and full FY26.
  • Results for the quarter and financial year ended March 31, 2026, were approved.
  • The Audit Committee and Board of Directors approved the results on May 25, 2026.
  • The filing includes Audited Financial Results, Auditor's Report, and financial statements.
  • Independent Auditor's Report by Prateek Jain & Co. provided an unmodified opinion.
👥 What This Means For Shareholders
✅
Action Required
No action required from shareholders based on this filing.
👤
Who Is Affected
All shareholders are informed of the completion of the FY26 audit and the submission of results, awaiting the detailed financial figures for review.
🔍
Management Signal
Management completed the regulatory requirement to submit audited financial results for FY26 in compliance with SEBI Regulations 30 and 33.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Review the detailed financial results once published for specific Q4 FY26 and FY26 figures.
Monitor future filings for operational and business updates following the financial year end.
Check for any dividend declarations or other board decisions that might follow the results approval.
LOW RISK The filing is a routine regulatory submission of audited financial results with an unmodified audit opinion.
💡 Investor Takeaway
Choksi Laboratories Limited has completed the submission of its Audited Financial Results for the fourth quarter and financial year ended March 31, 2026. The Independent Auditor's Report issued an unmodified opinion. Specific financial figures for the period are not detailed in this filing.
⚖️ Strengths & Concerns

✅ Positives

  • The Independent Auditor's Report by Prateek Jain & Co. provided an unmodified opinion on the financial results for the quarter and year ended March 31, 2026.
  • The financial results include a full year of data for FY26, as audited figures were presented for the period April 1, 2025, to March 31, 2026.

⚠️ Concerns

  • The filing only provides a confirmation of submission and auditor's opinion, without including the specific financial figures for Q4 FY26 or full FY26.
  • Absence of specific revenue, profit, and balance sheet figures in the submitted document limits detailed financial analysis of the period.
❓ Frequently Asked Questions
What event did Choksi Laboratories Limited disclose on May 25, 2026?
Choksi Laboratories Limited disclosed the submission of its Audited Financial Results along with the Audit Report for the Fourth Quarter and Financial Year ended March 31, 2026.
Which regulations does this Choksi Laboratories filing comply with?
This filing by Choksi Laboratories Limited complies with Regulation 30 & 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Who approved the financial results for Choksi Laboratories Limited?
The Audited Financial Results for Choksi Laboratories Limited were duly approved by the Audit Committee and Board of Directors in their respective meetings held on May 25, 2026.
What was the opinion of the independent auditor for Choksi Laboratories Limited's FY26 results?
Prateek Jain & Co., the independent auditor for Choksi Laboratories Limited, issued an unmodified opinion on the quarterly and year-to-date financial results for the period ended March 31, 2026.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.